Biotechnology Stocks II Performance Guide: Mineralys Therapeutics, Inc. (MLYS)
MLYS has no dividends.
Table and Chart of MLYS Performance
See what a $1,000 investment in MLYS is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| MLYS Returns | |
|---|---|
| Start Date | Mar-31-2023 |
| Start Price | $15.66 |
| End Date | May-16-2024 |
| End Price | $13.15 |
| # Prices | 15 |
| Min Date | Nov-30-2023 |
| Min Price | $6.66 |
| Max Date | Jun-30-2023 |
| Max Price | $17.05 |
| Total Return | -16.03% |
| Annualized Return | -13.04% |
| Current Value of $1,000 Purchase | $840 |
| Number Returns | 105 |
| Average Return | -1.72% |
| Number Profitable Returns | 39 |
| Percent Profitable Returns | 37.14% |
| Number Unprofitable Returns | 66 |
| Percent Unprofitable Returns | 62.86% |
| Profitable to Unprofitable Returns Ratio | 0.59 |
| MLYS Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $651,388,000 |
| Beta | Price to Sales |
| Earnings per Share | $-2.1800 |
| PE Ratio | None |
| PE to Growth Ratio | None |
| Price to Book | 2.671 |
| PRICE DATA | |
| 52 Week High | $17.44 |
| 52 Week Low | $5.85 |
| Analyst Target Price | $33.5 |
| 50-Day Moving Average | $12.81 |
| 200-Day Moving Average | $10.93 |
| FINANCIAL DATA | |
| Revenue per Share | $0 |
| Revenue | $0 |
| Profit Margin | 0% |
| Return on Equity | -29.1% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
MLYS Compare Returns with S&P 500
MLYS Trendline Chart
MLYS Moving Average Chart
MLYS Stock Return Map - See Patterns of Gains and Losses
MLYS Stock Returns/Purchase Dates